How three hospitals are countering rising drug prices August 25, 2016 By Aine Cryts Rising drug costs are a big problem for all healthcare systems in the U.S. Here’s how three hospitals are addressing the problem. Four things executives need to know to combat rising drug spend Executives need to ask themselves four key questions to mitigate the negative impact of rising drug costs. Biosimilar drugs appear comparable to brand-name counterparts August 07, 2016 By Tracey Walker Systematic review provides comprehensive first look at TNF-alpha biosimilar treatments. Drug pipeline: Anti-obesity meds August 02, 2016 By Tracey Walker Obesity and associated comorbidities strain the healthcare system, so why has R&D for new weight loss medications been lackluster? CMS proposal to address antibiotic resistance: Key takeaways July 26, 2016 By Mari Edlin To participate in Medicare and Medicaid, hospital and critical access hospitals (CAHs) would need to meet new criteria. Opinion: Mail-order pharmacy market to grow significantly July 19, 2016 By Andrew Lyle Shifting patient demographics will create an ideal scenario for the online/mail-order pharmacy market in the next five to ten years. Risky antibiotic use threatens patients July 14, 2016 By Tracey Walker A new study suggests that patients are willing to use antibiotics without contacting a doctor. Here’s how execs can curb this and avoid antibiotic resistance. How four health plans are fighting the opioid epidemic July 09, 2016 By Mari Edlin From new outreach programs to multidisciplinary teams, here are some new strategies health plans are employing to fight the opioid epidemic Asthma drug pipeline: Prevalence, costs to increase July 06, 2016 By Erin Bastick As asthma prevalence continues to rise in the adult and pediatric populations, U.S. healthcare spending on medications, especially branded inhalers, is expected to increase. Increased utilization driving pharmacy spend in exchange plans July 06, 2016 By Tracey Walker Express Scripts Exchange Pulse report found that utilization, particularly for traditional meds, was one of the biggest factors driving spending in 2015, accounting for more than half of the exchange plans $99 PMPY increase in spending between 2014 and 2015.